TNF and cancer: The agonists for some of the co-stimulating receptors of the immunoglobulin (CD28, ICOS) and tumor necrosis factor (4-1BB, CD27, GITR, OX40) superfamily have been evaluated for cancer therapy [29,121,122,123].